the aid library

LIST OPTIONS

Filter

1976

Sort by:

Direction:

Download (89)

View PDF (124)

Association between Ambient Temperature and Hospitalization for Renal Diseases in Brazil during 2000–2015: A Nationwide Case-Crossover Study

Bo Wen, Rongbin Xu, Yao Wu, Micheline de Sousa Zanotti Stagliorio Coelho et al. The Lancet Regional Health – Americas (2021) CC

Climate change is increasing the risks of injuries, diseases, and deaths globally. However, the association between ambient temperature and renal diseases has not been fully characterized. This study aimed to quantify the risk and attributable burden for hospitalizations of renal diseases related to... more

Download (522)

View PDF (741)

Drug resistant TB in South Africa – Hospitalization, statistics & costs

A. Kanabus TBFacts.org (2017) C2

Accessed November 2017

Download (97)

View PDF (95)

Guia de Practica clinica de Cuidados de Enfermeria unidad de hospitalizacion medicina

Ministerio de Salud - Peru (2017) C1

Las guias de Practica clinicas de Cuidados de Enfermeria constituyen los Diagnòsticos de Enfermeria que son la segunda etapa del proceso de enfermeria en la que se analizan los datos recogidos del paciente mediante la valoraciòn, con la finalidad de identificar los problemas que constituyen la bas... more

Download (86)

View PDF (128)

Guidance for implementing home care of people not Requiring - Hospitalization for Coronavirus disease (COVID-19)

Ministry of Health, Singapore National Environment Agency (Safeguard-Nurture,Cherish) (2020) C2

Interim Guidance 18th March 2020

Download (90)

View PDF (835)

Socioeconomic inequality in vulnerability to all-cause and cause-specific hospitalisation associated with temperature variability: a time-series study in 1814 Brazilian cities

Rongbin Xu, Qi Zhao, M.S.Z.S. Coelho et al. (2020) CC

The Lancet Planetary Health Volume 4, ISSUE 12, e566-e576, December 01, 2020. Exposure to temperature variability has been associated with increased risk of mortality and morbidity. We aimed to evaluate whether the association between short-term temperature variability and hospitalisation was affect... more

Download (91)

View PDF (656)

Reducing Antimicrobial Resistance and Hospital-Associated Infections: The Role of the Hospitalist

Dressler D. D., MD, MSc Director OF Society of Hospital Medicine (2005) CC

While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi... more

Download (40)

View PDF (34)

The Treatment of Heart Failure with Reduced Ejection Fraction

Berliner, D.; Hänselmann, A.; Bauersachs, J. Deutsches Ärzteblatt International (2020) CC

Background Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death. Methods This review is based on articles retrieved by a selective search in PubMed, as well as on r... more

Download (72)

View PDF (958)

Support for Rehabilitation: Self-Management after COVID-19 Related Illness

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

This leaflet provides support and advice for adults who are recovering from COVID-19. It can be used by individuals after hospitalization from the illness and those in the community who did not need hospitalization. The leaflet can complement care received from health care professionals. This is the... more

Download (63)

View PDF (626)

COVID-19 Scenarios

Ivan Aksamentov Nicholas Noll Richard Neher University of Basel (2020) C1

This web application serves as a planning tool for COVID-19 outbreaks in communities across the world. It implements a simple SIR (Susceptible-Infected-Recovered) model with additional categories for individuals exposed to the virus that are not yet infectious, severely sick people in need of hospit... more

Download (216)

View PDF (353)

Annual Hospital Statistics Report 2013

The Republic of the Union of Myanmar, Ministry of Health, Department of Public Health (2015) C1

This report is intended to provide information regarding reporting status of the public and private hospitals, availability and utilization of hospital services, performance of the hospitals under administration of Ministry of Health, hospital deliveries and leading causes of hospitalization and mor... more

Download (88)

View PDF (929)

Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand

Apisarnthanarak A.,S. Danchaivijitr,T. Khawcharoenporn, et al. (2006) C2

Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de... more

Download (91)

View PDF (391)

Infection de plaies dans la pratique clinique: Principes des bonnes pratiques

International Wound Infection Institute (2022) CC

L’infection d’une plaie demeure problématique pour les personnes présentant une plaie, leur famille et les professionnels de santé. L’infection d’une plaie peut entraîner un retard de la cicatrisation, de multiples visites aux services de soins et une durée d’hospitalisation accrue. ... more

Download (92)

View PDF (124)

Infection prevention and control in the household management of people with suspected or confirmed coronavirus disease (COVID-19)

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.

Download (1118)

View PDF (1614)

LA PRISE EN CHARGE DU PALUDISME GRAVE - Troisième Édition

World Health Organisation (WHO) (2013) C_WHO

Le présent guide pratique de prise en charge du paludisme grave et de ses complications est la troisième révision et actualisation de l'ouvrage. Il est destiné prioritairement aux professionnels de santé; travaillant dans des hôpitaux ou des centres de santé disposant de structures d'hospital... more

Download (224)

View PDF (170)

Guía Práctica de cuidados paliativos en situación de pandemia COVID-29. - El Salvador 2020

ASEDP (Asociación Salvadoreña para el Estudio y Tratamiento del Dolor y Cuidados Paliativos) ; PALIAMED (Fundación de Medicina Paliativa de El Salvador); Hospital Divina Providencia; et al. (2020) C2

San Salvador, 11 de abril de 2020 En una situación de crisis como la que estamos viviendo es muy probable que los profesionales de salud que atiendan a pacientes con COVID-19 avanzado, enfrenten situaciones nuevas y complejas en que se noten con limitaciones en el actuar e incapaces para toma de... more

Download (98)

View PDF (925)

Guía para el Control de Infecciones Asociadas a la Atención en Salud

International Society for Infectious Diseases (2019) C2

Escrita por expertos internacionales en los campos de control de infecciones y epidemiología hospitalaria, la Guía para el Control de Infecciones Asociadas a la Atención en Saludde ISID reúne los principios e intervenciones más recientes que permitirán reducir la tasa de infección y el impact... more

Download (259)

View PDF (355)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (150)

View PDF (159)

Mental health, human rights and legislation: Guidance and practice

UN Office of the High Commissioner for Human Rights OHCHR, World Health Organization WHO (2023) C_WHO

WHO-OHCHR launch new guidance to improve laws addressing human rights abuses in mental health care Ahead of World Mental Health Day, the World Health Organization (WHO) and the Office of the High Commissioner on Human Rights (OHCHR) are jointly launching a new guidance, entitled "Mental health, h... more

Download (172)

View PDF (239)

Monkeypox Case Report Form (CRF) (Arabic)

World Health Organization WHO (2022) C_WHO

21 July 2022. The Rapid Core CRF is designed to collect data obtained through examination, interview and review of hospital or clinic notes of patients with suspected, probable, or confirmed monkeypox infection. Data may be collected prospectively or retrospectively. The data collection period is ... more

Download (107)

View PDF (132)

Strategy to Achieve Global Covid-19 Vaccination by mid-2022

World Health Organisation (WHO) (2021) C_WHO

Every country has been affected by COVID-19, with nearly a quarter of a billion cases and almost 5 million deaths reported globally as of end of September 2021. Despite the stunning speed with which highly effective and safe vaccines have been developed, new waves of disease are still pushin... more